Eiji Miyauchi

Eiji Miyauchi

Auto-generated profile, based on publicly available information

Eiji Miyauchi

RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2022 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
EMEiji Miyauchi
Eiji Miyauchi
CSChikako Shimokawa
Chikako Shimokawa
ASAlex Steimle
Alex Steimle
MDMahesh Desai
Mahesh Desai
HOHiroshi Ohno
Hiroshi Ohno

14 July 2021 in Nature
Verified
Journal Article
Closed access
PDF file
TTTadashi Takeuchi
Tadashi Takeuchi
EMEiji Miyauchi
Eiji Miyauchi
TKTakashi Kanaya
Takashi Kanaya
TKTamotsu Kato
Tamotsu Kato
YNYumiko Nakanishi
Yumiko Nakanishi
HOHiroshi Ohno
Hiroshi Ohno

22 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JJJianshi Jin
Jianshi Jin
RYReiko Yamamoto
Reiko Yamamoto
TTTadashi Takeuchi
Tadashi Takeuchi
GCGuangwei Cui
Guangwei Cui
EMEiji Miyauchi
Eiji Miyauchi
KSKatsuyuki Shiroguchi
Katsuyuki Shiroguchi
The bacterial microbiota works as a community that consists of many individual organisms, i.e., cells. To fully understand the function of bacterial microbiota, individual cells must be identified; however, it is difficult with current techniques. Here, we develop a method, Barcoding Bacteria for Identification and Quantification (BarBIQ), which classifies single bacterial cells into taxa–named herein cell-based operational taxonomy units (cOTUs)–based on cellularly barcoded 16S rRNA sequences with single-base accuracy, and quantifies the cell number for each cOTU in the microbiota in a high-throughput manner. We apply BarBIQ to murine cecal microbiotas and quantify in total 3.4 × 105 bacterial cells containing 810 cOTUs. Interestingly, we find location-dependent global differences in the cecal microbiota depending on the dietary vitamin A deficiency, and more differentially abundant cOTUs at the proximal location than the distal location. Importantly, these location differences are not clearly shown by conventional 16S rRNA gene-amplicon sequencing methods, which quantify the 16S rRNA genes, not the cells. Thus, BarBIQ enables microbiota characterization with the identification and quantification of individual constituent bacteria, which is a cornerstone for microbiota studies.

25 August 2025 in Gut
Verified
Journal Article
Closed access
PDF file
EMEiji Miyauchi
Eiji Miyauchi
TTTakashi Taida
Takashi Taida
KUKan Uchiyama
Kan Uchiyama
YNYumiko Nakanishi
Yumiko Nakanishi
TKTamotsu Kato
Tamotsu Kato
HOHiroshi Ohno
Hiroshi Ohno
Background: The aetiology and pathogenesis of IBD are intricate, involving genetic and environmental factors. Notably, cigarette smoking has contrasting effects, being detrimental to Crohn’s disease (CD) and beneficial to UC. However, the mechanisms underlying these opposite effects remain unclear. Objective: This study aimed to elucidate the precise mechanisms by which smoking influences IBD pathogenesis, by focusing on the roles of microbiota and metabolomics. Design: We analysed the microbiota composition of saliva, faeces and the colonic mucosa, and the faecal metabolite profile of patients with IBD and healthy participants. The effects of smoking-associated bacteria on the gut immune system and colitis were evaluated using gnotobiotic mice and murine models of UC and CD. Results: People with UC who smoke showed increased concentrations of short-chain fatty acids and aromatic compounds in the faeces compared with the people who quit smoking. The analysis of the mucosal microbiota revealed that smoking is associated with the increased oral bacteria in the colonic mucosa. Monocolonisation of germ-free mice with Streptococcus mitis , one of the oral bacteria ectopically increased in the colonic mucosa, induced interferon (IFN)-γ-producing T cells in the colon. S. mitis also attenuated inflammation in a murine model of UC but exacerbated it in a CD model. Conclusion: We demonstrated that smoking affects the gut immune system by modulating mucosal microbiota. Our findings provide insights into how smoking can have beneficial or detrimental effects on UC or CD, respectively, and may shed light on the reasons why individuals with UC who quit smoking experience disease exacerbation.

12 February 2014 in Nature
Verified
Journal Article
Open access
PDF file
YFYukihiro Furusawa
Yukihiro Furusawa
YOYuuki Obata
Yuuki Obata
SFShinji Fukuda
Shinji Fukuda
TETakaho A. Endo
Takaho A. Endo
GNGaku Nakato
Gaku Nakato
HOHiroshi Ohno
Hiroshi Ohno
Erratum: Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

13 November 2024 in International Journal of Laboratory Hematology
Verified
Journal Article
Open access
NGNanami Gotoh
Nanami Gotoh
TOTsukasa Oda
Tsukasa Oda
YKYuya Kitamura
Yuya Kitamura
NSNatsuki Shiraishi
Natsuki Shiraishi
RARuna Aoyagi
Runa Aoyagi
Takayuki SaitohTakayuki Saitoh
Takayuki Saitoh
Introduction: The link between DNA repair gene polymorphisms and cancer susceptibility has gained significant attention. Thus, we investigated the impact of base excision repair (BER) gene polymorphisms on acute myeloid leukemia (AML) risk and pathogenesis.Methods: In total, 106 patients with AML and 191 healthy controls were included in the study, wherein polymorphisms in four BER genes (APEX1, MUTYH, OGG1, and XRCC1) were examined.Results: Notably, the APEX1‐656 T>G polymorphism exhibited a significant association with AML risk in the recessive (TT vs. TG + GG) (p = 0.046) and co‐dominant models (TT vs. GG) (p = 0.02). Assessing APEX1 expression levels, APEX1 expression was elevated in the bone marrow of patients with AML compared with that in controls (p = 0.02). Subsequently, we compared the percentages of CD34+ cells between the APEX1 high or low expression groups, revealing a significant difference (high vs. low = 29.9% vs. 11.5%, p = 0.01). Additionally, we observed reduced APEX1 expression in HL60 cells differentiated with all‐trans retinoic acid (p < 0.001). We hypothesized that APEX1 expression could correlate with stemness and analyzed its expression in stem and differentiated cells.Conclusions: In the GSE48558 dataset, AML cells and normal CD34+ cells expressed APEX1 at higher levels than did granulocytes (p < 0.01). Functional experiments revealed that APEX1 knockdown led to a reduction in AML cell proliferation. These findings indicated that APEX1 polymorphisms were a potential risk factor for AML and highlighted the important role of APEX1 in regulating AML cell differentiation and proliferation.